| 1. |
- Hillerstrom, Hampus, et al.
(författare)
-
Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome.
- 2024
-
Ingår i: Alzheimer's & Dementia. - 1552-5260 .- 1552-5279. ; 20:8, s. 3649-3656
-
Tidskriftsartikel (refereegranskat)abstract
- Prior authorization criteria for Federal Drug Administration (FDA) approved immunotherapeutics, among the class of anti-amyloid monoclonal antibodies (mAbs), established by state drug formulary committees, are tailored for adults with late-onset Alzheimer's disease. This overlooks adults with Down syndrome (DS), who often experience dementia at a younger age and with different diagnostic assessment outcomes. This exclusion may deny DS adults access to potential disease-modifying treatments. To address this issue, an international expert panel convened to establish adaptations of prescribing criteria suitable for DS patients and parameters for access to Centers for Medicare & Medicaid Services (CMS) registries. The panel proposed mitigating disparities by modifying CMS and payer criteria to account for younger onset age, using alternative language and assessment instruments validated for cognitive decline in the DS population. The panel also recommended enhancing prescribing clinicians' diagnostic capabilities for DS and initiated awareness-raising activities within healthcare organizations. These efforts facilitated discussions with federal officials, aimed at achieving equity in access to anti-amyloid immunotherapeutics, with implications for national authorities worldwide evaluating these and other new disease-modifying therapeutics for Alzheimer's disease.
|
|
| 2. |
- Ouellette-Kuntz, Hélène, et al.
(författare)
-
How best to support individuals with IDD as they become frail : Development of a consensus statement
- 2019
-
Ingår i: Journal of Applied Research in Intellectual Disabilities. - : Wiley. - 1360-2322 .- 1468-3148. ; 32:1, s. 35-42
-
Tidskriftsartikel (refereegranskat)abstract
- Background: While higher rates and earlier onset of frailty have been reported among adults with intellectual and developmental disabilities (IDD), research on how best to support these individuals is lacking. Method: An international consultation relied on three consensus building methods: the Nominal Group Technique, an NIH consensus conference approach, and a Delphi survey. Results: There is agreement that person-centered planning and aging in place should be guiding principles. Frailty must be considered earlier than in the general population with the recognition that improvement and maintenance are viable goals. Intersectoral collaboration is needed to coordinate assessments and actions. Safety and planning for the future are important planning considerations, as are the needs of caregivers. Ongoing research is needed. Conclusion: The statement offers guidance to respond to frailty among adults with IDD and fosters ongoing exchange internationally on best practice. As new evidence emerges, the statement should be revisited and revised.
|
|
